{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "BIOGEND THERAPEUTICS CO LTD", "longName": "BioGend Therapeutics Co., Ltd.", "messageBoardId": "finmb_549634353", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChangePercent": -2.7523015, "regularMarketPrice": 37.1, "marketState": "POSTPOST", "firstTradeDateMilliseconds": 1560819600000, "priceHint": 2, "epsTrailingTwelveMonths": -1.72, "sharesOutstanding": 123076000, "bookValue": 6.819, "fiftyDayAverage": 33.397, "fiftyDayAverageChange": 3.702999, "fiftyDayAverageChangePercent": 0.1108782, "twoHundredDayAverage": 24.952896, "twoHundredDayAverageChange": 12.147102, "twoHundredDayAverageChangePercent": 0.4868013, "marketCap": 4667847680, "priceToBook": 5.4406805, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -1.050003, "regularMarketTime": 1684128637, "regularMarketDayHigh": 38.15, "regularMarketDayRange": "36.75 - 38.15", "regularMarketDayLow": 36.75, "regularMarketVolume": 1625378, "regularMarketPreviousClose": 38.15, "bid": 37.1, "ask": 37.15, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 38.0, "averageDailyVolume3Month": 2092767, "averageDailyVolume10Day": 1843800, "fiftyTwoWeekLowChange": 17.999998, "fiftyTwoWeekLowChangePercent": 0.94240826, "fiftyTwoWeekRange": "19.1 - 47.4", "fiftyTwoWeekHighChange": -10.300003, "fiftyTwoWeekHighChangePercent": -0.21729964, "fiftyTwoWeekLow": 19.1, "fiftyTwoWeekHigh": 47.4, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "6733.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No.3-2, Park Street", "address2": "4th Floor Nangang District", "city": "Taipei", "zip": "115", "country": "Taiwan", "phone": "886 2 2655 8366", "website": "https://www.biogend.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BioGend Therapeutics Co., Ltd. develops regenerative bio-orthopaedic products. It is developing BiG-001 and BiG-006, an osteoinductive bone graft substitute; and BiG-009, an autologous cartilage repair system. The company was founded in 2016 and is based in Taipei, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Prof. Te-Li  Chen M.D., Ph.D.", "title": "Chairman & GM", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}